| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |